MAPT and Alzheimer disease: Interestingly, pseudo-phosphorylation at Ser262 increased the levels of tau phosphorylated at additional sites, as recognized by AD-relevant antibodies [12] including phospho-Ser199 and AT8 (pS202 and pT205) (Figure 9).